MENU
ATHE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alterity Therapeutics (ATHE) Ownership - Who owns Alterity Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
350 Collins Street
Phone
+61 393494906
Employees
11
Web
https://www.alteritytherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.41M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATHE
Capitalization
23.4M
P/E Ratio
N/A
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
N/A
P/B Ratio
2.16
Cash Flow
N/A
Earnings
-3.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
6.17
Current Revenue Per Employee
9166.06
Dividends Per Share - Security
N/A
EBITDA
-14.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.21
Shares Held By Institutions
261K
Shares Outstanding - Current
8.74M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
-1
Gain YTD
-8.835
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
350 Collins Street
Phone
+61 393494906
Employees
11
Web
https://www.alteritytherapeutics.com